glp-1 news today pharma today A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for Lilly's GLP-1 pill seen as

Understanding their uses, side effects, administration, precautions, interactions, and the impact of lifestyle and diet is important for anyone using these medications

Sweetgreen refined its Plates line for macro-conscious, post-GLP consumers focused on nutrient density

Patskovsky YV, Huang MQ, Takayama T, Listowsky I, Pearson WR

A separate 2026 systematic review in the medical journal, The BMJ, found that weight returned at an average rate of about 0.4 kilograms roughly one pound per month after stopping weight-management medication, putting many patients on track to return to their starting weight within about 1.5 to 2 years without ongoing treatment

GLP-1 drug users by working status According to the data, users generally fall into higher income brackets, with most GLP-1 users falling into the higher and intermediate management roles